These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10881693)

  • 21. The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer.
    Saleh M; Jonas NK; Wiegmans A; Stylli SS
    Gene Ther; 2000 Oct; 7(20):1715-24. PubMed ID: 11083492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR; McCloskey G; Wright MA; Pak AS
    Cancer Immunol Immunother; 1994 Jan; 38(1):9-15. PubMed ID: 8299123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
    Tzeng JJ; Barth RF; Orosz CG; James SM
    Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines.
    Tseng SH; Hwang LH; Lin SM
    J Immunother; 1997 Sep; 20(5):334-42. PubMed ID: 9336740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of central and peripheral immunomodulation in a murine glioma model.
    Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN
    BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
    Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
    Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M; Hofer MJ; Roth E; Pircher HP; Pagenstecher A
    J Neuropathol Exp Neurol; 2009 May; 68(5):525-34. PubMed ID: 19525900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.
    Kurosawa S; Harada M; Matsuzaki G; Shinomiya Y; Terao H; Kobayashi N; Nomoto K
    Immunology; 1995 Jun; 85(2):338-46. PubMed ID: 7642226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
    Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
    Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery.
    Graf MR; Prins RM; Poulsen GA; Merchant RE
    J Neuroimmunol; 2003 Jul; 140(1-2):49-60. PubMed ID: 12864971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
    Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
    Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.
    Mao J; Cao M; Zhang F; Zhang J; Duan X; Lu L; Yang Z; Zhang X; Zhu W; Zhang Q; Wang Z; Shen J
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.
    Miyatake S; Nishihara K; Kikuchi H; Yamashita J; Namba Y; Hanaoka M; Watanabe Y
    J Natl Cancer Inst; 1990 Feb; 82(3):217-20. PubMed ID: 2104938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.
    Ehtesham M; Samoto K; Kabos P; Acosta FL; Gutierrez MA; Black KL; Yu JS
    Cancer Gene Ther; 2002 Nov; 9(11):925-34. PubMed ID: 12386831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.
    Clavreul A; Delhaye M; Jadaud E; Menei P
    J Neurooncol; 2006 Aug; 79(1):9-17. PubMed ID: 16575532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gamma-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy.
    Wen PY; Lampson MA; Lampson LA
    J Neuroimmunol; 1992 Jan; 36(1):57-68. PubMed ID: 1735769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. lacZ-neoR transfected glioma cells in syngeneic rats: growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS.
    Visted T; Thorsen J; Thorsen F; Read TA; Ulvestad E; Engebraaten O; Sorensen D; Ylä-Herttuala S; Tyynela K; Rucklidge G; Edvardsen K; Bjerkvig R; Lund-Johansen M
    Int J Cancer; 2000 Jan; 85(2):228-35. PubMed ID: 10629082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.
    Badie B; Schartner JM
    Neurosurgery; 2000 Apr; 46(4):957-61; discussion 961-2. PubMed ID: 10764271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.